Survival of lymphocytes is not restricted by IDO-expressing fibroblast from rheumatoid arthritis patients.
Massalska M, Kuca-Warnawin E, Janicka I, Plebanczyk M, Pawlak D, Dallos T, Olwert A, Radzikowska A, Maldyk P, Kontny E, Maslinski W.
Massalska M, et al. Among authors: pawlak d.
Immunopharmacol Immunotoxicol. 2019 Apr;41(2):214-223. doi: 10.1080/08923973.2019.1569048. Epub 2019 Feb 4.
Immunopharmacol Immunotoxicol. 2019.
PMID: 30714436